M. Hall

发表

Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.

C. Marsden, P. Jenner, N. Rupniak, 1982, Biochemical pharmacology.

Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of l-DOPA to rats

C. Marsden, P. Jenner, D. Cooper, 1984, Neuropharmacology.

Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats

C. Marsden, P. Jenner, P. Jenner, 1984, Neuropharmacology.

Cation regulation differentiates specific binding of [3 H]sulpiride and [3 H]spiperone to rat striatal preparations

P. Jenner, P. Jenner, C. Marsden, 1980, The Journal of pharmacy and pharmacology.

Expression and characterisation of human and rat CRF2α receptors

P. Carnell, R. Mackenzie, R. Franks, 1999 .

Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.

C. Marsden, P. Jenner, R. Dyer, 1981, European journal of pharmacology.

Detection of the interleukin 18 family in rat brain by RT-PCR.

N. Rothwell, A. Culhane, S. Pickering-Brown, 2000, Brain research. Molecular brain research.

Cloning of rat brain interleukin-18 cDNA

N. Rothwell, A. Culhane, G. Luheshi, 1998, Molecular Psychiatry.

Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs

C. Marsden, Gavin Kilpatrick, P. Jenner, 2005, Journal of Neural Transmission.

Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression

K. Lee, R. H. Scott, R. Pinnock, 2002, Neuropharmacology.

PD 165929 — the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonist

R. Jordan, R. A. Lewthwaite, A. McKnight, 1996 .

Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer.

L. Pardo, S. Ferré, Alessandro Bonifazi, 2022, Pharmacological research.

The interleukin-1 type I receptor is expressed in human hypothalamus.

D. Smart, J. Hughes, S. Toulmond, 1999, Brain : a journal of neurology.

Characterisation using microphysiometry of CRF receptor pharmacology.

D. Smart, A. McKnight, C. Rossant, 1999, European journal of pharmacology.

Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine.

C. Marsden, P. Jenner, P. Jenner, 1983, European journal of pharmacology.

[3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain

M. Hamon, M. Emerit, S. Mestikawy, 1985, Journal of neurochemistry.

Corticotropin-Releasing Factor Type 1 and Type 2α Receptors Regulate Phosphorylation of Calcium/Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein and Activation of p42/p44 Mitogen-Activated Protein Kinase.

J. Hughes, R. Pinnock, C. Rossant, 1999, Endocrinology.

Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.

F. Artaud, M. Hamon, S. Bourgoin, 1984, European journal of pharmacology.

Cholecystokinin receptors

J. Hughes, P. Boden, M. Hall, 2005, Cellular and Molecular Neurobiology.

Activation of astrocyte intracellular signaling pathways by interleukin‐1 in rat primary striatal cultures

S. Mcnulty, M. Hall, E. A. Young, 2002, Glia.

Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

C. Marsden, Gavin Kilpatrick, P. Jenner, 2004, Psychopharmacology.

In situ molecular sizes of the various types of 5-HT binding sites in the rat brain.

M. Hamon, M. Emerit, M. Nielsen, 1986, Biochemical pharmacology.

Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat

C. Marsden, Gavin Kilpatrick, P. Jenner, 2004, Psychopharmacology.

Irreversible blockade of central 5-HT binding sites by 8-methoxy-2'-chloro-PAT.

M. Hamon, M. Emerit, A. Marquet, 1985, Biochemical pharmacology.

Differential anatomical location of [3H]‐N,n‐propylnorapomorphine and [3 H]‐spiperone binding sites in the striatum and substantia nigra of the rat

P. Jenner, C. Marsden, E. Kelly, 1983, British journal of pharmacology.

Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.

C. Marsden, P. Jenner, P. Jenner, 1983, Biochemical pharmacology.

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

C. Marsden, Gavin Kilpatrick, P. Jenner, 1985, Biochemical pharmacology.

PD 165929 - The First High Affinity Non-Peptide Neuromedin-B (NMB) Receptor Selective Antagonist.

R. Jordan, R. A. Lewthwaite, A. McKnight, 1997 .

Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.

C. Marsden, P. Jenner, M. Hall, 1983, Biochemical pharmacology.